🇺🇸 BNT162b2 vaccine in United States

BNT162b2 vaccine (BNT162b2 vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pricing & reimbursement

BNT162b2 vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is BNT162b2 vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for BNT162b2 vaccine in United States?

Vaxxinity, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does BNT162b2 vaccine cost in United States?

annual_list: USD 0.00 per year. Final patient cost depends on reimbursement and any patient access scheme.